CBD Life Sciences Inc. (CBDL)

Market Cap	1.14M -0.3%
Revenue (ttm)	178.45K +29.1%
Net Income	-107.44K
EPS	-0.00
Shares Out	5.70B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	781,841
Average Volume	4,325,191
Open	0.0002
Previous Close	0.0002
Day's Range	0.0001 - 0.0002
52-Week Range	0.0001 - 0.0010
Beta	86.64
RSI	51.75
Earnings Date	n/a

About CBD Life Sciences

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Lisa Nelson
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: CBDL

Financial Performance

In 2023, CBD Life Sciences's revenue was $167,147, an increase of 4.31% compared to the previous year's $160,241. Losses were -$78,574, -90.86% less than in 2022.